The role of the leukemia inhibitory factor (LIF) - Pathway in derivation and maintenance of murine pluripotent stem cells

Genes

Volumn 2, Issue 1, 2011, Pages 280-297

  Graf, Urs ^a   Casanova, Elisa A ^a   Cinelli, Paolo ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Embryonic stem cells; Induced pluripotent stem cells; LIF; Pluripotency; STAT3

Indexed keywords

GLYCOPROTEIN GP 130; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; STAT3 PROTEIN;

ANIMAL CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL RENEWAL; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENDODERM; ENZYME ACTIVATION; MESODERM; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN FUNCTION; REVIEW;

MURINAE;

EID: 79953687107     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes2010280     Document Type: Review

References (90)

1. Fukada, T.; Hibi, M.; Yamanaka, Y.; Takahashi-Tezuka, M.; Fujitani, Y.; Yamaguchi, T.; Nakajima, K.; Hirano, T. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis. Immunity 1996, 5, 449-460.
2. Takahashi-Tezuka, M.; Yoshida, Y.; Fukada, T.; Ohtani, T.; Yamanaka, Y.; Nishida, K.; Nakajima, K.; Hibi, M.; Hirano, T. Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase. Mol. Cell Biol. 1998, 18, 4109-4117.
3. Brazil, D.P.; Yang, Z.-Z.; Hemmings, B.A. Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem. Sci. 2004, 29, 233-242.
4. Stewart, C.L.; Kaspar, P.; Brunet, L.J.; Bhatt, H.; Gadi, I.; Köntgen, F.; Abbondanzo, S.J. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992, 359, 76-79.
5. Dani, C.; Chambers, I.; Johnstone, S.; Robertson, M.; Ebrahimi, B.; Saito, M.; Taga, T.; Li, M.; Burdon, T.; Nichols, J.; Smith, A. Paracrine induction of stem cell renewal by LIF-deficient cells: A new ES cell regulatory pathway. Dev. Biol. 1998, 203, 149-162.
6. Hu, W.; Feng, Z.; Teresky, A.K.; Levine, A.J. p53 regulates maternal reproduction through LIF. Nature 2007, 450, 721-724.
7. Ware, C.B.; Horowitz, M.C.; Renshaw, B.R.; Hunt, J.S.; Liggitt, D.; Koblar, S.A.; Gliniak, B.C.; McKenna, H.J.; Papayannopoulou, T.; Thoma, B.; et al. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 1995, 121, 1283-1299.
8. Li, M.; Sendtner, M.; Smith, A. Essential function of LIF receptor in motor neurons. Nature 1995, 378, 724-727.
9. Yoshida, K.; Taga, T.; Saito, M.; Suematsu, S.; Kumanogoh, A.; Tanaka, T.; Fujiwara, H.; Hirata, M.; Yamagami, T.; Nakahata, T.; Hirabayashi, T.; Yoneda, Y.; Tanaka, K.; Wang, W.Z.; Mori, C.; Shiota, K.; Yoshida, N.; Kishimoto, T. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA 1996, 93, 407-411.
10. Nichols, J.; Chambers, I.; Taga, T.; Smith, A. Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines. Development 2001, 128, 2333-2339.
11. Evans, M.J.; Kaufman, M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292, 154-156.
12. Escary, J.L.; Perreau, J.; Duménil, D.; Ezine, S.; Brûlet, P. Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature 1993, 363, 361-364.
13. Boiani, M.; Schöler, H.R. Regulatory networks in embryo-derived pluripotent stem cells. Nat. Rev. Mol. Cell Biol. 2005, 6, 872-884.
14. Conquet, F.; Peyriéras, N.; Tiret, L.; Brûlet, P. Inhibited gastrulation in mouse embryos overexpressing the leukemia inhibitory factor. Proc. Natl. Acad. Sci. USA 1992, 89, 8195-8199.
15. Mahdavi, A.; Davey, R.E.; Bhola, P.; Yin, T.; Zandstra, P.W. Sensitivity analysis of intracellular signaling pathway kinetics predicts targets for stem cell fate control. PLoS Comput. Biol. 2007, 3, e130.
16. Ware, C.B.; Horowitz, M.C.; Renshaw, B.R.; Hunt, J.S.; Liggitt, D.; Koblar, S.A.; Gliniak, B.C.; McKenna, H.J.; Papayannopoulou, T.; Thoma, B. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 1995, 121, 1283-1299.
17. Takeda, K.; Noguchi, K.; Shi, W.; Tanaka, T.; Matsumoto, M.; Yoshida, N.; Kishimoto, T.; Akira, S. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA 1997, 94, 3801-3804.
18. Matsuda, T.; Nakamura, T.; Nakao, K.; Arai, T.; Katsuki, M.; Heike, T.; Yokota, T. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. Embo. J. 1999, 18, 4261-4269.
19. Ying, Q.-L.; Wray, J.; Nichols, J.; Batlle-Morera, L.; Doble, B.; Woodgett, J.; Cohen, P.; Smith, A. The ground state of embryonic stem cell self-renewal. Nature 2008, 453, 519-523.
20. Boyle, K.; Zhang, J.; Nicholson, S.; Trounson, E.; Babon, J.; McManus, E.; Nicola, N.; Robb, L. Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation. Cell Signal. 2008, 21, 394-404.
21. Duval, D.; Reinhardt, B.; Kedinger, C.; Boeuf, H. Role of suppressors of cytokine signaling (Socs) in leukemia inhibitory factor (LIF) -dependent embryonic stem cell survival. Faseb J. 2000, 14, 1577-1584.
22. Li, Y.; McClintick, J.; Zhong, L.; Edenberg, H.J.; Yoder, M.C.; Chan, R.J. Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood 2005, 105, 635-637.
23. Forrai, A.; Boyle, K.; Hart, A.H.; Hartley, L.; Rakar, S.; Willson, T.A.; Simpson, K.M.; Roberts, A.W.; Alexander, W.S.; Voss, A.K.; Robb, L. Absence of suppressor of cytokine signalling 3 reduces self-renewal and promotes differentiation in murine embryonic stem cells. Stem Cells 2006, 24, 604-614.
24. Takahashi, Y.; Carpino, N.; Cross, J.C.; Torres, M.; Parganas, E.; Ihle, J.N. SOCS3: An essential regulator of LIF receptor signaling in trophoblast giant cell differentiation. EMBO J. 2003, 22, 372-384.
25. Takahashi, Y.; Takahashi, M.; Carpino, N.; Jou, S.-T.; Chao, J.-R.; Tanaka, S.; Shigeyoshi, Y.; Parganas, E.; Ihle, J.N. Leukemia inhibitory factor regulates trophoblast giant cell differentiation via Janus kinase 1-signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway. Mol. Endocrinol. 2008, 22, 1673-1681.
26. Chung, B.M.; Kang, H.C.; Han, S.Y.; Heo, H.S.; Lee, J.J.; Jeon, J.; Lim, J.Y.; Shin, I.; Hong, S.H.; Cho, Y.S.; Kim, C.G. Jak2 and Tyk2 are necessary for lineage-specific differentiation, but not for the maintenance of self-renewal of mouse embryonic stem cells. Biochem. Biophys. Res. Commun. 2006, 351, 682-688.
27. Ernst, M.; Oates, A.; Dunn, A.R. Gp130-mediated signal transduction in embryonic stem cells involves activation of Jak and Ras/mitogen-activated protein kinase pathways. J. Biol. Chem. 1996, 271, 30136-30143.
28. Rodig, S.J.; Meraz, M.A.; White, J.M.; Lampe, P.A.; Riley, J.K.; Arthur, C.D.; King, K.L.; Sheehan, K.C.; Yin, L.; Pennica, D.; Johnson, E.M.; Schreiber, R.D. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 1998, 93, 373-383.
29. Neubauer, H.; Cumano, A.; Müller, M.; Wu, H.; Huffstadt, U.; Pfeffer, K. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 1998, 93, 397-409.
30. Yang, W.; Klaman, L.D.; Chen, B.; Araki, T.; Harada, H.; Thomas, S.M.; George, E.L.; Neel, B.G. An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival. Dev. Cell. 2006, 10, 317-327.
31. Chan, R.J.; Johnson, S.A.; Li, Y.; Yoder, M.C.; Feng, G.-S. A definitive role of Shp-2 tyrosine phosphatase in mediating embryonic stem cell differentiation and hematopoiesis. Blood 2003, 102, 2074-2080.
32. Wu, D.; Pang, Y.; Ke, Y.; Yu, J.; He, Z.; Tautz, L.; Mustelin, T.; Ding, S.; Huang, Z.; Feng, G.-S. A conserved mechanism for control of human and mouse embryonic stem cell pluripotency and differentiation by shp2 tyrosine phosphatase. PLoS ONE 2009, 4, e4914.
33. Martin, G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 1981, 78, 7634-7638.
34. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126, 663-676.
35. Solter, D.; Knowles, B.B. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc. Natl. Acad. Sci. USA 1978, 75, 5565-5569.
36. Schöler, H.R. Octamania: The POU factors in murine development. Trends Genet. 1991, 7, 323-329.
37. Scholer, H.R.; Balling, R.; Hatzopoulos, A.K.; Suzuki, N.; Gruss, P. Octamer binding proteins confer transcriptional activity in early mouse embryogenesis. EMBO J. 1989, 8, 2551-2557.
38. Mitsui, K.; Tokuzawa, Y.; Itoh, H.; Segawa, K.; Murakami, M.; Takahashi, K.; Maruyama, M.; Maeda, M.; Yamanaka, S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003, 113, 631-642.
39. Chambers, I.; Colby, D.; Robertson, M.; Nichols, J.; Lee, S.; Tweedie, S.; Smith, A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003, 113, 643-655.
40. Thomson, J.A.; Itskovitz-Eldor, J.; Shapiro, S.S.; Waknitz, M.A.; Swiergiel, J.J.; Marshall, V.S.; Jones, J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282, 1145-1147.
41. Ying, Q.L.; Nichols, J.; Chambers, I.; Smith, A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 2003, 115, 281-292.
42. Sato, N.; Meijer, L.; Skaltsounis, L.; Greengard, P.; Brivanlou, A.H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 2004, 10, 55-63.
43. Tang, H.; Hornstein, E.; Stolovich, M.; Levy, G.; Livingstone, M.; Templeton, D.; Avruch, J.; Meyuhas, O. Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation. Mol. Cell Biol. 2001, 21, 8671-8683.
44. Meyuhas, O. Synthesis of the translational apparatus is regulated at the translational level. Eur. J. Biochem. 2000, 267, 6321-6330.
45. Smith, A.G.; Heath, J.K.; Donaldson, D.D.; Wong, G.G.; Moreau, J.; Stahl, M.; Rogers, D. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 1988, 336, 688-690.
46. Gearing, D.P.; Gough, N.M.; King, J.A.; Hilton, D.J.; Nicola, N.A.; Simpson, R.J.; Nice, E.C.; Kelso, A.; Metcalf, D. Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). EMBO J. 1987, 6, 3995-4002.
47. Williams, R.L.; Hilton, D.J.; Pease, S.; Willson, T.A.; Stewart, C.L.; Gearing, D.P.; Wagner, E.F.; Metcalf, D.; Nicola, N.A.; Gough, N.M. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 1988, 336, 684-687.
48. Ying, Q.-L.; Smith, A.G. Defined conditions for neural commitment and differentiation. Meth. Enzymol. 2003, 365, 327-341.
49. Storm, M.P.; Bone, H.K.; Beck, C.G.; Bourillot, P.-Y.; Schreiber, V.; Damiano, T.; Nelson, A.; Savatier, P.; Welham, M.J. Regulation of Nanog expression by phosphoinositide 3-kinase-dependent signaling in murine embryonic stem cells. J. Biol. Chem. 2007, 282, 6265-6273.
50. Watanabe, S.; Umehara, H.; Murayama, K.; Okabe, M.; Kimura, T.; Nakano, T. Activation of Akt signaling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells. Oncogene 2006, 25, 2697-2707.
51. Paling, N.R.D.; Wheadon, H.; Bone, H.K.; Welham, M.J. Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling. J. Biol. Chem. 2004, 279, 48063-48070.
52. Kunath, T.; Saba-El-Leil, M.K.; Almousailleakh, M.; Wray, J.; Meloche, S.; Smith, A. FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 2007, 134, 2895-2902.
53. Boeuf, H.; Merienne, K.; Jacquot, S.; Duval, D.; Zeniou, M.; Hauss, C.; Reinhardt, B.; Huss-Garcia, Y.; Dierich, A.; Frank, D.A.; Hanauer, A.; Kedinger, C. The ribosomal S6 kinases, cAMP-responsive element-binding, and STAT3 proteins are regulated by different leukemia inhibitory factor signaling pathways in mouse embryonic stem cells. J. Biol. Chem. 2001, 276, 46204-46211.
54. Niwa, H.; Burdon, T.; Chambers, I.; Smith, A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 1998, 12, 2048-2060.
55. Yoshida, K.; Chambers, I.; Nichols, J.; Smith, A.; Saito, M.; Yasukawa, K.; Shoyab, M.; Taga, T.; Kishimoto, T. Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways. Mech. Dev. 1994, 45, 163-171.
56. Nichols, J.; Chambers, I.; Smith, A. Derivation of germline competent embryonic stem cells with a combination of interleukin-6 and soluble interleukin-6 receptor. Exp. Cell Res. 1994, 215, 237-239.
57. Raz, R.; Lee, C.K.; Cannizzaro, L.A.; d'Eustachio, P.; Levy, D.E. Essential role of STAT3 for embryonic stem cell pluripotency. Proc. Natl. Acad.Sci. USA 1999, 96, 2846-2851.
58. Cinelli, P.; Casanova, E.A.; Uhlig, S.; Lochmatter, P.; Matsuda, T.; Yokota, T.; Rülicke, T.; Ledermann, B.; Bürki, K. Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. BMC Dev. Biol. 2008, 8, 57.
59. Xie, X.; Chan, K.; Cao, F.; Huang, M.; Li, Z.; Lee, A.; Weissman, I.; Wu, J. Imaging of STAT3 Signaling Pathway During Mouse Embryonic Stem Cell Differentiation. Stem Cells Dev. 2008, 18, 205-214.
60. Trouillas, M.; Saucourt, C.; Guillotin, B.; Gauthereau, X.; Ding, L.; Buchholz, F.; Doss, M.X.; Sachinidis, A.; Hescheler, J.; Hummel, O.; Huebner, N.; Kolde, R.; Vilo, J.; Schultz, H.; Boeuf, H. Three LIF-dependent signatures and gene clusters with atypical expression profiles, identified by transcriptome studies in mouse ES cells and early derivatives. BMC Genomics 2009, 10, 73.
61. Sekkaï, D.; Gruel, G.; Herry, M.; Moucadel, V.; Constantinescu, S.N.; Albagli, O.; Tronik-Le Roux, D.; Vainchenker, W.; Bennaceur-Griscelli, A. Microarray analysis of LIF/Stat3 transcriptional targets in embryonic stem cells. Stem Cells 2005, 23, 1634-1642.
62. Cartwright, P.; McLean, C.; Sheppard, A.; Rivett, D.; Jones, K.; Dalton, S. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 2005, 132, 885-896.
63. Bourillot, P.; Aksoy, I.; Schreiber, V.; Wianny, F.; Schulz, H.; Hummel, O.; Hubner, N.; Savatier, P. Novel STAT3 target genes exert distinct roles in the inhibition of mesoderm and endoderm differentiation in cooperation with Nanog. Stem Cells 2009, 10.1002/stem.110.
64. Hall, J.; Guo, G.; Wray, J.; Eyres, I.; Nichols, J.; Grotewold, L.; Morfopoulou, S.; Humphreys, P.; Mansfield, W.; Walker, R.; Tomlinson, S.; Smith, A. Oct4 and LIF/Stat3 Additively Induce Krüppel Factors to Sustain Embryonic Stem Cell Self-Renewal. Cell Stem Cell 2009, 5, 597-609.
65. Fan, Y.; Melhem, M.F.; Chaillet, J.R. Forced expression of the homeobox-containing gene Pem blocks differentiation of embryonic stem cells. Dev. Biol. 1999, 210, 481-496.
66. Casanova, E.A.; Shakhova, O.; Patel, S.S.; Asner, I.N.; Pelczar, P.; Weber, F.A.; Graf, U.; Sommer, L.; Bürki, K.; Cinelli, P. Pramel7 Mediates LIF/STAT3 Dependent Self-Renewal in Embryonic Stem Cells. Stem Cells 2010, 10.1002/stem.588.
67. Chen, X.; Xu, H.; Yuan, P.; Fang, F.; Huss, M.; Vega, V.B.; Wong, E.; Orlov, Y.L.; Zhang, W.; Jiang, J.; Loh, Y.-H.; Yeo, H.C.; Yeo, Z.X.; Narang, V.; Govindarajan, K.R.; Leong, B.; Shahab, A.; Ruan, Y.; Bourque, G.; Sung, W.-K.; Clarke, N.D.; Wei, C.-L.; Ng, H.-H. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008, 133, 1106-1117.
68. Aksoy, I.; Sakabedoyan, C.; Bourillot, P.-Y.; Malashicheva, A.B.; Mancip, J.; Knoblauch, K.; Afanassieff, M.; Savatier, P. Self-renewal of murine embryonic stem cells is supported by the serine/threonine kinases pim-1 and pim-3. Stem Cells 2007, 25, 2996-3004.
69. Niwa, H.; Ogawa, K.; Shimosato, D.; Adachi, K. A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 2009, 460, 118-122.
70. Nichols, J.; Silva, J.; Roode, M.; Smith, A. Suppression of Erk signalling promotes ground state pluripotency in the mouse embryo. Development 2009, 136, 3215-3222.
71. Burdon, T.; Stracey, C.; Chambers, I.; Nichols, J.; Smith, A. Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev. Biol. 1999, 210, 30-43.
72. Lloyd, A.C. Ras versus cyclin-dependent kinase inhibitors. Curr. Opin. Genet. Dev. 1998, 8, 43-48.
73. Wang, Y.; Wang, F.; Sun, T.; Trostinskaia, A.; Wygle, D.; Puscheck, E.; Rappolee, D.A. Entire mitogen activated protein kinase (MAPK) pathway is present in preimplantation mouse embryos. Dev. Dyn. 2004, 231, 72-87.
74. Maekawa, M.; Yamamoto, T.; Kohno, M.; Takeichi, M.; Nishida, E. Requirement for ERK MAP kinase in mouse preimplantation development. Development 2007, 134, 2751-2759.
75. Lewis, T.S.; Shapiro, P.S.; Ahn, N.G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 1998, 74, 49-139.
76. Takahashi, K.; Mitsui, K.; Yamanaka, S. Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature 2003, 423, 541-545.
77. Jirmanova, L.; Afanassieff, M.; Gobert-Gosse, S.; Markossian, S.; Savatier, P. Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells. Oncogene 2002, 21, 5515-5528.
78. Hallmann, D.; Trümper, K.; Trusheim, H.; Ueki, K.; Kahn, C.R.; Cantley, L.C.; Fruman, D.A.; Hörsch, D. Altered signaling and cell cycle regulation in embryonal stem cells with a disruption of the gene for phosphoinositide 3-kinase regulatory subunit p85alpha. J. Biol. Chem. 2003, 278, 5099-5108.
79. Moon, R.T.; Kohn, A.D.; De Ferrari, G.V.; Kaykas, A. WNT and beta-catenin signalling: Diseases and therapies. Nat. Rev. Genet. 2004, 5, 691-701.
80. Nelson, W.J.; Nusse, R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004, 303, 1483-1487.
81. Burdon, T.; Smith, A.; Savatier, P. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell. Biol. 2002, 12, 432-438.
82. Jeong, C.-H.; Cho, Y.-Y.; Kim, M.-O.; Kim, S.-H.; Cho, E.-J.; Lee, S.-Y.; Jeon, Y.-J.; Lee, K.Y.; Yao, K.; Keum, Y.-S.; Bode, A.M.; Dong, Z. Phosphorylation of Sox2 cooperates in reprogramming to pluripotent stem cells. Stem Cells 2010, 28, 2141-2150.
83. Wilmut, I.; Schnieke, A.E.; McWhir, J.; Kind, A.J.; Campbell, K.H. Viable offspring derived from fetal and adult mammalian cells. Nature 1997, 385, 810-813.
84. Egli, D.; Rosains, J.; Birkhoff, G.; Eggan, K. Developmental reprogramming after chromosome transfer into mitotic mouse zygotes. Nature 2007, 447, 679-685.
85. Wakayama, T.; Perry, A.C.; Zuccotti, M.; Johnson, K.R.; Yanagimachi, R. Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature 1998, 394, 369-374.
86. Takahashi, K.; Okita, K.; Nakagawa, M.; Yamanaka, S. Induction of pluripotent stem cells from fibroblast cultures. Nat. Protoc. 2007, 2, 3081-3089.
87. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131, 861-872.
88. Heng, J.-C.D.; Feng, B.; Han, J.; Jiang, J.; Kraus, P.; Ng, J.-H.; Orlov, Y.L.; Huss, M.; Yang, L.; Lufkin, T.; Lim, B.; Ng, H.-H. The Nuclear Receptor Nr5a2 Can Replace Oct4 in the Reprogramming of Murine Somatic Cells to Pluripotent Cells. Cell Stem Cell 2010, 6, 167-174.
89. Okita, K.; Nakagawa, M.; Hyenjong, H.; Ichisaka, T.; Yamanaka, S. Generation of Mouse Induced Pluripotent Stem Cells without Viral Vectors. Science 2008, 322, 949-953.
90. Yang, J.; van Oosten, A.L.; Theunissen, T.W.; Guo, G.; Silva, J.C.R.; Smith, A. Stat3 Activation Is Limiting for Reprogramming to Ground State Pluripotency. Cell Stem Cell 2010, 7, 319-328.